The Yaz lawyers at The Law Office of Bobby Garcia, P.C. are evaluating potential lawsuits for users of the Yasmin or Yaz birth control pill who have suffered serious blood-clot injuries or other problems.
Yaz, which is nearly identical to Yasmin birth control, is a newer type of oral contraceptive sold by Bayer. It has been aggressively marketed without adequate warnings about serious and potentially life-threatening side effects.
WOMEN MAY BE ENTITLED TO FINANCIAL COMPENSATION THROUGH A YAZ SETTLEMENT IF THEY HAVE SUFFERED FROM A:
Individual lawsuits and Yaz birth control class action lawsuits are being reviewed throughout the United States, and there are no fees or expenses unless a recovery is obtained. To review a potential case, request a free consultation and claim evaluation.
REVIEW A CASE
Yaz (droperinone & ethinyl estradiol) is a once-a-day birth control pill that was first approved by the FDA in March 2006 to prevent unwanted pregnancy. In October 2006, approval was expanded to include treatment of the emotional and physical symptoms of premenstrual dysphoric disorder (PMDD), which is a more severe version of PMS that interferes with daily activities. In January 2007, it was also approved to treat moderate acne in women who already desire birth control.
Known as a combined oral contraceptive, Yaz contains ethinyl estradiol (estrogen that affects the release of eggs) and drospirenone (progestin that interferes with the lining of the uterus). Drospirenone is unique to Yaz, Yasmin and generic Ocella, making these newer birth control pills potentially more dangerous than other oral contraceptives.
Drospirenone can increase blood potassium levels, known as hyperkalemia, which can result in the Yaz heart problems and other side effects. Individuals who have pre-existing kidney, liver and adrenal disease could be particularly susceptible.
ALLEGATIONS IN YAZ LAWSUITS
Throughout the United States, a number of Yaz birth control lawsuits have been filed against Bayer Healthcare Pharmaceuticals, Inc., which was formerly known as Berlex, Inc. and Berlex Laboratories, Inc., alleging that the drug makers:
Failed to adequately warn consumers and the medical community about the potential risk of Yaz side effects.
Failed to adequately test and research Yaz birth control before placing it on the market, which could have shown that users will face an increased risk of heart attacks, strokes, pulmonary embolism, deep vein thrombosis, gallbladder complications and other life-threatening health problems.
Failed to issue a Yaz recall or remove the birth control pill from the market after it became apparent that it is an unreasonably dangerous drug, for which the harmful side effects outweigh any potential benefits provided over other available birth control pills.
Aggressively marketed Yaz and encouraged misuse and overuse despite the known Yaz dangers to maximize profits at the expense of users’ health.
The drug makers had sole access to facts concerning the potential Yaz problems, and ignored the correlation between their drug and potentially life-threatening side effects. Yaz safety concerns were concealed and misrepresentations were made to to convince potential users and the medical community to use the birth control pill instead of other available products. This increased the drug makers’ profits at the expense of women throughout the United States.
Your email address will not be published. Required fields are marked *
This site uses Akismet to reduce spam. Learn how your comment data is processed.